Abstract Library

Welcome to the open-access search for all ENETS abstracts presented at the Annual ENETS Conferences.

Everyone can browse the library to find basic information on abstracts. To get full access to each entry, you will be asked to log in to your myENETS account.

 

Please note:

Participants of the 2025 ENETS Conference enjoy full access to the 2025 conference digital resources through myENETS: the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more.

Log in to myENETS

ENETS Abstract Search

#3311 Clinical management of neuroendocrine neoplasms (NENs) in the time of COVID-19

Introduction: The current SARS-CoV-2 virus epidemic is an exceptional global health situation, very serious for already fragile patients such as cancer patients. These patients are at much higher risk (4 to5 times) of severe respiratory complications, which develop very quickly, especially since they will have received surgery or chemotherapy in the preceding weeks, putting their vital prognosis at risk, in addition to the risk of cancer «double jeopardy».

Conference: 18th Annual ENETS Concerence (2021)

Presenting Author:

Authors: Bengueddach A, Kehili H, Kaid M, Bereksi Reguig F, Tidjene A,

Keywords: COVID-19, SARS-CoV-2, neuroendocrine,

#3268 Management and treatment of neuroendocrine tumors during the global COVID-19 pandemic - Experience of medical oncology department of hospital 1st November

Introduction: The current recommendations for management of neuroendocrine tumor diseases are still evolving, due to the limited experience on this issue. As the new coronavirus can be transmitted through breath droplets, by contact, there is no consensus of how this fact may affect the investigation and treatment of neuroendocrine tumor diseases.

Conference: 18th Annual ENETS Concerence (2021)

Presenting Author:

Authors: Bengueddach A, Kaid M, Kehili H, Tidjene A, Bereksi Reguig F,

Keywords: neuroendocrine, covid-19, treatment,

#2703 Carcinoid Heart Disease: A Retrospective Study and a Multidisciplinary Proposal of a New Algorithm

Introduction: Development of carcinoid heart disease (CHD) is the major negative prognostic factor in patients with the carcinoid syndrome. The only effective treatment is valve replacement. However, the selection of candidates and determination of optimal timing remain unclear. Considerable variability in local treatment strategies exist

Conference: 17th Annual ENETSConcerence (2020)

Presenting Author:

Authors: Bengueddach A, Kehili H, Kaid M, Bereksi Reguig F, Bousahba A,

Keywords: carcinoid heart disease, somatostatin analogue, neuroendocrine tumors,